A transformation path that was accelerated by the pandemic, but that, despite much evolution over the last three years, still has an unfinished marathon. (...) This optimistic view of evolution is apparently shared by the NHS users surveyed by the Health Sustainability Index, conducted by NOVA IMS, with the support of Abbvie pharmaceuticals.